NasdaqGM - Nasdaq Real Time Price USD
Harrow, Inc. (HROW)
At close: October 21 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
154,146.00
130,193.00
88,595.00
72,476.00
48,871.00
--
Cost of Revenue
44,461.00
39,640.00
25,383.00
18,214.00
14,463.00
--
Gross Profit
109,685.00
90,553.00
63,212.00
54,262.00
34,408.00
--
Operating Expense
117,834.00
89,742.00
61,293.00
52,399.00
33,660.00
--
Operating Income
-8,149.00
811.00
1,919.00
1,863.00
748.00
--
Net Non Operating Interest Income Expense
-21,759.00
-21,324.00
-7,244.00
-5,436.00
-2,236.00
--
Other Income Expense
-2,010.00
-3,197.00
-8,686.00
-14,301.00
-1,927.00
--
Pretax Income
-31,918.00
-23,710.00
-14,011.00
-17,874.00
-3,415.00
--
Tax Provision
1,659.00
701.00
75.00
133.00
4.00
--
Net Income Common Stockholders
-33,577.00
-24,411.00
-14,086.00
-18,479.00
-3,357.00
--
Diluted NI Available to Com Stockholders
-33,577.00
-24,411.00
-14,086.00
-18,479.00
-3,357.00
--
Basic EPS
-0.95
-0.75
-0.51
-0.69
-0.13
--
Diluted EPS
-0.95
-0.75
-0.51
-0.69
-0.13
--
Basic Average Shares
35,199.26
32,616.78
27,619.61
26,781.16
25,823.08
--
Diluted Average Shares
35,199.26
32,616.78
27,619.61
26,781.16
25,823.08
--
Total Operating Income as Reported
-8,529.00
431.00
1,919.00
1,614.00
385.00
--
Total Expenses
162,295.00
129,382.00
86,676.00
70,613.00
48,123.00
--
Net Income from Continuing & Discontinued Operation
-33,577.00
-24,411.00
-14,086.00
-18,007.00
-3,357.00
--
Normalized Income
-32,165.27
-22,236.13
-15,938.55
-11,317.28
-5,468.16
--
Interest Expense
21,759.00
21,324.00
7,244.00
--
--
--
Net Interest Income
-21,759.00
-21,324.00
-7,244.00
-5,436.00
-2,236.00
--
EBIT
-10,159.00
-2,386.00
-6,767.00
1,863.00
748.00
--
EBITDA
2,464.00
9,954.00
-3,102.00
4,259.00
3,491.00
--
Reconciled Cost of Revenue
44,461.00
39,640.00
25,383.00
18,214.00
14,463.00
--
Reconciled Depreciation
12,623.00
12,340.00
3,665.00
2,396.00
2,743.00
--
Net Income from Continuing Operation Net Minority Interest
-33,577.00
-24,411.00
-14,086.00
-18,007.00
-3,357.00
--
Total Unusual Items Excluding Goodwill
-1,787.00
-2,753.00
2,345.00
-9,164.00
2,892.00
--
Total Unusual Items
-1,787.00
-2,753.00
2,345.00
-9,164.00
2,892.00
--
Normalized EBITDA
4,251.00
12,707.00
-5,447.00
13,423.00
599.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-375.27
-578.13
492.45
-2,474.28
780.84
--
12/31/2019 - 9/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ETON Eton Pharmaceuticals, Inc.
8.44
+1.08%
LNTH Lantheus Holdings, Inc.
112.08
-3.95%
AMRX Amneal Pharmaceuticals, Inc.
8.47
-1.28%
CPHRF Cipher Pharmaceuticals Inc.
11.95
+1.79%
HCM HUTCHMED (China) Limited
20.85
-0.24%
BIOA BioAge Labs, Inc.
25.83
+8.26%
NBIX Neurocrine Biosciences, Inc.
116.57
-1.22%
EOLS Evolus, Inc.
16.24
-2.29%
SUPN Supernus Pharmaceuticals, Inc.
33.67
-2.52%
TKNO Alpha Teknova, Inc.
6.62
-9.19%